SCHEMBL6560067

SCHEMBL6560067

COC(=O)C(C)c1ccc(SC(=O)N(C)C)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
SLC6A3 Q01959 6/20 0.38
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
ACHE P22303 1/20 0.35
HPGD P15428 1/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
AKR1C3 P42330 2/20 0.34
AKR1C2 P52895 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12982518 0.82 MT-CO2 (0.45) MT-CO2PTGS1PTGS2SLC6A3PSEN1
SCHEMBL1626214 0.77 SLC6A3 (0.57) MT-CO2PTGS1PTGS2SLC6A3SLC6A2
SCHEMBL6561512 0.76 MT-CO2 (0.35) MT-CO2ACHE
SCHEMBL3483627 0.75 ALDH1A1 (0.40) HPGDSLC6A4TDP1
SCHEMBL9063569 0.74 MT-CO2 (0.55) MT-CO2PTGS1PTGS2SLC6A3HPGD
SCHEMBL17891807 0.74 MT-CO2 (0.55) MT-CO2PTGS1PTGS2SLC6A3PSEN1
SCHEMBL10931210 0.73 MT-CO2 (0.47) MT-CO2PTGS1PTGS2SLC6A3PSEN1
SCHEMBL17891802 0.73 MT-CO2 (0.47) MT-CO2PTGS1PTGS2SLC6A3PSEN1
SCHEMBL29749568 0.73 MT-CO2 (0.47) MT-CO2PTGS1PTGS2SLC6A3PSEN1
SCHEMBL2067938 0.73 AKR1C3 (0.55) MT-CO2PTGS1PTGS2SLC6A3TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0904079-B1 ANTIDIABETIC AGENTS MERCK & CO INC (US) 2004-03-24 EP disclosed
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0904079-A4 1999-05-06 EP disclosed
EP-0904079-A1 ANTIDIABETIC AGENTS Merck & Co., Inc. (US) 1999-03-31 EP disclosed
US-5859051-A ACETYLPHENOL DERIVATIVES MERCK & CO., INC. (US) 1999-01-12 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997027857-A1 ANTIDIABETIC AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed